LONDON, 18th March 2024 – Meysey, a fraud protection startup that utilises artificial intelligence (AI), has successfully raised £250,000. This funding will be used to develop AI-powered fraud protection software specifically designed for small and medium-sized enterprises (SMEs). Read More
NOTTINGHAM, United Kingdom, 18 March 2024 – Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialisation. Neupulse’s recently finalised working prototype stimulates Read More
InvenireX, a Newcastle-based biotech company that aims to disrupt the market for PCR laboratory tests, has raised £500,000 in funding from DSW Ventures and XTX Ventures. InvenireX’s platform, which incorporates AI and Read More
This will close in 25 seconds
